10:05 – 10:22 (17mins) Weekly: Nate Lucas
Communications Director for U.S. Rep. Eric Burlison (MO-07)
for more information on Nate, go to NateLucas.com - @nlucas0 

10:25 – 10:37 (17mins)  Weekly Feature: “PORCELLI’S DELI!!”

10:41 – 10:56 (15mins)  Dr. Salvatore J. Giorgianni, Jr., PharmD.  
Senior Science Adviser to the Men's Health Network and a Past-Chair/Chair-Emeritus of the American Public Health Association and former Alumni Association Board Member of Columbia University School of Public Health.
Trump Signs Executive Order to Fast-Track Ibogaine Research — Bringing New Hope to Veterans Battling PTSDTrump signs order to fast track psychedelic drug research to treat veterans with PTSD
On April 18, 2026, President Donald Trump signed a groundbreaking executive order directing federal agencies to accelerate research into ibogaine — a Schedule I psychedelic drug derived from an African shrub — as a potential breakthrough treatment for veterans suffering from PTSD, traumatic brain injury, depression, anxiety, suicidal ideation, and opioid addiction.